Medicare Enrolled

Dr. Parmanand Singh, MD

Cardiovascular Disease · Boston, MA
Practice pattern: Cardiac Imaging — Practice with significant diagnostic imaging and stress testing
Low-engagement
55 FRUIT ST, Boston, MA 02114
8666448910
In practice since 2008 (18 years)
NPI: 1194902437 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Singh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Singh? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Singh

Dr. Parmanand Singh is a cardiovascular disease specialist in Boston, MA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Singh performed 1,125 Medicare services across 837 unique beneficiaries.

Between the years covered by Open Payments, Dr. Singh received a total of $544 from 14 pharmaceutical and/or device companies across 23 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Singh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ 1,125 Medicare services $544 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,125
Medicare services
Bottom 43% in MA for cardiovascular disease
837
Unique beneficiaries
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~62 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Regadenoson injection (Lexiscan) for heart stress test
An injection of regadenoson, a medication used to stress the heart during diagnostic testing.
160 $41 $215
EKG interpretation and report
A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report.
140 $7 $36
Technetium Tc-99m sestamibi diagnostic injection
A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies.
130 $86 $250
Echocardiogram, transthoracic
An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function.
122 $127 $1,304
Nuclear stress test of heart muscle
A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera.
101 $284 $1,929
Exercise or drug-induced heart stress test with ECG
A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review.
68 $57 $450
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
67 $120 $257
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
64 $67 $250
New patient office visit, complex (60-74 min) 54 $153 $393
Exercise or drug-induced heart stress test with ECG
A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results.
43 $12 $129
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
28 $110 $426
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
28 $147 $590
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
26 $101 $293
Heart muscle strain imaging 25 $10 $37
Exercise or drug-induced heart stress test with ECG
A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision.
19 $18 $64
Continuous ECG monitoring, up to 30 days
Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results.
19 $21 $117
Follow-up heart ultrasound
An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress.
18 $20 $120
Aminophylline injection, up to 250 mg
Administration of aminophylline medication via injection for a dose of up to 250 mg.
13 $10 $25
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.8% high complexity
51.3% medium
37.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$544
Total received (2018-2024)
Avg $182/year across 3 years
Bottom 40% in MA for cardiovascular disease
14
Companies
23
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$544 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$207
2023
$294
2018
$44

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$28
Amgen Inc.
$28
PFIZER INC.
$26
Kiniksa Pharmaceuticals International, plc
$26
Merck Sharp & Dohme LLC
$23
Abbott Laboratories
$23
AstraZeneca Pharmaceuticals LP
$20
United Therapeutics Corporation
$16
E.R. Squibb & Sons, L.L.C.
$15
Top 3 companies account for 40.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$98
Amgen Inc.
$73
Merck Sharp & Dohme LLC
$47
PFIZER INC.
$47
Boehringer Ingelheim Pharmaceuticals, Inc.
$45
E.R. Squibb & Sons, L.L.C.
$36
SCPHARMACEUTICALS INC.
$35
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$28
Kiniksa Pharmaceuticals, Ltd.
$28
Kiniksa Pharmaceuticals International, plc
$26
Abbott Laboratories
$23
Lantheus Medical Imaging, Inc.
$22
Janssen Pharmaceuticals, Inc
$21
United Therapeutics Corporation
$16
Top 3 companies account for 40.2% of all-time payments
Associated products mentioned in payments ›
Arcalyst · CAMZYOS · DEFINITY · ELIQUIS · FARXIGA · FUROSCIX · IMFINZI · JARDIANCE · JOT DX · LifeVest · Repatha · VERQUVO · VYNDAQEL · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a cardiovascular disease specialist in Boston?
Compare cardiologists in the Boston area by procedure volume, costs, and industry payment transparency.
Browse cardiologists nearby

Geographic Context

Cardiologists within 10 mi
594
Per 100K population
75.9
County median income
$92,859
Nearest hospital
MASSACHUSETTS GENERAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Singh is a cardiac imaging specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Singh experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Singh performed 160 regadenoson injection (lexiscan) for heart stress test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Singh receive payments from pharmaceutical companies?
Yes. Dr. Singh received a total of $544 from 14 companies across 23 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Singh's costs compare to other cardiologists in Boston?
Dr. Singh's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Singh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →